Retatrutide is a triple agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. It has attracted significant research interest as a next-generation metabolic compound, with studies examining its effects on body weight, glucose regulation, and cardiometabolic markers. It represents one of the most advanced compounds in current obesity and metabolic disease research.
For research use only. Not intended for human or animal consumption. Not evaluated by the FDA.
Retatrutide is a triple agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. It has attracted significant research interest as a next-generation metabolic compound, with studies examining its effects on body weight, glucose regulation, and cardiometabolic markers. It represents one of the most advanced compounds in current obesity and metabolic disease research.
For research use only. Not intended for human or animal consumption. Not evaluated by the FDA.
Image 1 of 1
